No results for ‘’
Yash Innoventures Ltd
NSE: BSE: 523650
â‚ą34.01
(3.78%)
Mon, 27 Jul 2026, 10:32 am
Market Cap (in Cr)52.53
PE Ratio6.96
Dividend0
Distribution Services
Wholesale Distributors
24.5KYash Innoventures Analysis
dividend
- Unable to evaluate Redex Protech's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
- Unable to evaluate Redex Protech's dividend against the top 25% market benchmark as the company has not reported any payouts.
health
- Redex Protech is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Redex Protech is profitable, therefore cash runway is not a concern.
- Redex Protech is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (250%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 4.9x debt.
- Redex Protech's cash and other short term assets cover its long term commitments.
- Interest payments on debt are well covered by earnings (EBIT is 46x coverage).
- Redex Protech's level of debt (14.3%) compared to net worth is satisfactory (less than 40%).
- The level of debt compared to net worth has increased over the past 5 years (3.9% vs 14.3% today).
- High level of physical assets or inventory.
management
- The average tenure for the Redex Protech board of directors is over 10 years, this suggests they are a seasoned and experienced board.
misc
- Redex Protech is not covered by any analysts.
- BSE:523650 has not traded for 26 days.
past
- Redex Protech's 1-year earnings growth is negative, it can't be compared to the 5-year average.
- Redex Protech's year on year earnings growth rate was negative over the past 5 years and the most recent earnings are below average.
- Redex Protech used its assets less efficiently than the IN Commercial Services industry average last year based on Return on Assets.
- Redex Protech's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
- Redex Protech has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).
- Redex Protech's 1-year earnings growth is negative, it can't be compared to the IN Commercial Services industry average.
value
- Redex Protech's share price is below the future cash flow value, and at a moderate discount (> 20%).
- Redex Protech's share price is below the future cash flow value, and at a substantial discount (> 40%).
- 523650 outperformed the Commercial Services industry which returned -31.6% over the past year.
- 523650 outperformed the Market in India which returned -14.5% over the past year.
- Redex Protech is overvalued based on assets compared to the IN Commercial Services industry average.
- Redex Protech is overvalued based on earnings compared to the IN Commercial Services industry average.
- Redex Protech is overvalued based on earnings compared to the India market.
- BSE:523650 is down -1.6% underperforming the Commercial Services industry which returned 5.9% over the past month.
- BSE:523650 is down -1.6% underperforming the market in India which returned 8% over the past month.